Published: Saturday 10 February, 2018

Sale of Belo Beauty Products Stopped by Food & Drug Administration

The Belo Medical Group has been ordered to stop selling some of its beauty products. This after the Food and Drug Administration (FDA) discovered that some Belo cosmetic products are being sold without the agency’s approval.

Belo beauty products

Some Belo beauty products found to be unregistered with the FDA. (Belo Medical Group image)

FDA operatives conducted a test-buy operation on the Belo clinic in Alabang and found out that some beauty products have been mislabeled. Likewise, other Belo cosmetic products have not been registered with the FDA

“Food and Drug Administration (FDA) has served a summon with preventive measure order to Belo Medical Clinic Alabang to cease and desist from selling unregistered drugs and unnotified cosmetic products,” said the report of Maan Macapagal of ABS CBN News.

  Bagyong Ompong Update: Signal No. 4 Area Widens as #OmpongPH Makes Landfall

Due to this, the sale of the following Belo products have been stopped:

-ZO Medical by Zein Obagi;
-MD Glycogent Exfoliation Accelerator 10% concentration;
-ZO Medical by Zein Obagi Foamacleanse Gentle Foaming Cleanser for all types;

-ZO Medical by Zein Obagi Oclipse Sunscreen/Primer SPF 30 Protection;
-Belo Illuminating Cream Alpha Arbutin+Liquorice;
-Belo Prescriptives Keralyt 2 Cream;

– ZO Medical by Zein ObagiMD Melamix Skin Lightener & Blending Creme Hydroquinone USP 4%;
-ZO Medical by Zein Obagi MD Melanin Skin Bleaching & Correcting Creme Hydroquinone USP 4%;
-Belo Prescriptives Acne Astringent;

-Belo Prescriptives Belo White;
-Belo Prescriptives DLC Peeling Creme;
-ZO Medical by Zein Obagi MD Cebatrol.

  LOOK Russian Boy with 2-inch Long Eyelashes Unfazed by Attention He Gets

Moreover, the Belo Medical Group may face bigger sanctions after its operatives were prevented from inspecting the clinic’s clinic in Alabang. This is a violation of the law which, according to retired Gen. Allen Bantolo, chief of the FDA Regulatory Enforcement Unit, may lead to contempt and/or obstruction of justice charges against the company.

“Even nga yung kanilang pharmacy na under jurisdiction ng aming FDA [hindi pina-inspect], when in fact, nasa batas din yon na they are supposed to allow inspectors for inspection. May provisions yan na pwede silang ma-contempt or obstruction of justice,” Bantolo said.